A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)

Clinical trial NCT06177912 · COMPLETED

Trial details

NCT number: NCT06177912
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Infection

Start date: 2024-01-18
Primary completion: 2025-02-26
Enrollment: 882

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.